Angiotensin-Converting Enzyme Inhibitors

Introduction

  • First-line agents for pediatric heart failure and hypertension
  • Common agents: Captopril, Enalapril, Lisinopril, Ramipril
  • Proven safety profile in children with appropriate monitoring
  • Available in various formulations including oral solutions

Mechanism of Action

ACE inhibitors work through multiple pathways:

  • Inhibit conversion of angiotensin I to angiotensin II
  • Decrease aldosterone secretion
  • Increase bradykinin levels
  • Reduce sympathetic nervous system activity

Physiologic Effects

  • Vasodilation of both arterioles and venules
  • Reduction in total peripheral resistance
  • Decreased cardiac preload and afterload
  • Improved cardiac output without reflex tachycardia
  • Reduction in left ventricular remodeling

Clinical Indications

Primary Indications

  • Systolic heart failure
  • Hypertension (primary and secondary)
  • Proteinuric kidney diseases
  • Post-cardiac transplantation
  • Marfan syndrome (to slow aortic root dilation)
  • Single ventricle physiology

Specific Clinical Scenarios

  • Left-to-right shunts with pulmonary overcirculation
  • Dilated cardiomyopathy
  • Preservation of renal function in chronic kidney disease
  • Management of protein-losing enteropathy

Dosing Guidelines

Captopril

  • Initial: 0.1-0.3 mg/kg/dose
  • Frequency: Every 8-12 hours
  • Maximum: 6 mg/kg/day
  • Note: Start lower in neonates (0.05-0.1 mg/kg/dose)

Enalapril

  • Initial: 0.08-0.1 mg/kg/dose
  • Frequency: Every 12-24 hours
  • Maximum: 0.5 mg/kg/day
  • Note: Once-daily dosing possible in older children

Lisinopril

  • Initial: 0.07-0.1 mg/kg/dose once daily
  • Maximum: 0.5 mg/kg/day up to 40 mg/day
  • Note: Convenient once-daily dosing

Monitoring & Safety

Required Monitoring

  • Baseline: Blood pressure, serum creatinine, potassium, CBC
  • Follow-up: Blood pressure at 1-2 weeks
  • Labs: Creatinine and potassium at 1-2 weeks, then quarterly
  • Growth parameters in chronic therapy

Major Adverse Effects

  • Hypotension (especially first-dose)
  • Hyperkalemia
  • Acute kidney injury
  • Angioedema (rare but serious)
  • Chronic cough (10-20% of patients)

Contraindications

  • Pregnancy (teratogenic)
  • Bilateral renal artery stenosis
  • History of angioedema
  • Hyperkalemia

Key Practice Points

  • Start at lower doses in volume-depleted patients
  • Consider sodium restriction in resistant cases
  • Monitor white blood cell count in autoimmune conditions
  • Assess renal function before procedures requiring contrast
  • Hold during acute illness with dehydration risk


Further Reading
Powered by Blogger.